Geneesmiddelenbeleid

This procedure involves a motion in the Dutch House of Representatives regarding the national strategy for pharmaceutical policy. It focuses on how the government manages the availability, pricing, and distribution of medicines to ensure sustainable healthcare. This affects the Ministry of Health, pharmaceutical companies, and healthcare providers. It may lead to changes in how medications are procured or regulated to ensure patient access to essential drugs.